- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06869148
Evaluation of Prioritized Assessment for Older Patients Living With Frailty Presenting to the Emergency Department
The older population is getting older and growing in size worldwide. This requires healthcare to adapt to meet the complex medical and nursing needs of the older patient group. As older patients have varying health conditions with different levels of functions, their premise to handle acute, unexpected illness differs as well. This complicates matters for healthcare, especially emergency departments (ED) where resource allocation and identifying patients that are at greatest risk of negative health outcomes must be prioritized in a limited time.
When patients present to the ED, initial triage information such as vital signs and reason for visit determines the triage acuity for the patient. In Linköping, and large parts of Sweden, the triage tool RETTS (Rapid Emergency Triage and Treatment System) is used, where the highest priority is red (priority 1), then orange (priority 2), yellow (priority 3), green (priority 4) and blue (priority 5). However, this can be misleading when assessing older patients due to altered physiology with natural ageing and older patients are known to be under-triaged with existing triage systems.
The variation in functional capacity in older patients does not necessarily correlate with comorbidities and age and has been condensed to the term 'frailty'. It has been proposed that the frailty level corresponds more to biological age rather than chronological age. Frailty increases the risk of adverse outcomes such as falls, the need of in-hospital care, institutionalization, and mortality in which the risk is increased even in low acuity illnesses.
Frailty can be assessed by various means and based on the theory of cumulative deficit, frailty assessment instruments have been developed where frailty level increases with the amount of help needed from others. Different instruments have been compared in the ED and the Clinical Frailty Scale (CFS) have been deemed fit due to it being practical in a busy environment. The scale consists of 9 points where 9 is the highest level of frailty and the scale is usually dichotomized into "robust" and "living with frailty" where 5 points or above constitutes frailty. The prognostic value of CFS has previously been studied in the ED of University hospital of Linköping in Sweden with results indicating that the instrument should be used as an additional risk assessment in the ED.
Older patients often present with vague and complex symptoms to th ED, which could lead to prolonged ED stay due to the need of extensive medical workup or therapy. Long ED stays have been shown to increase both morbidity and mortality in older patients as well as risk of delirium and complications relating to care, especially in individuals living with frailty. In order to decrease the adverse events, aim to shorten ED length of stay (ED LOS) should therefore be a reasonable goal in clinical improvement work. Early identification of frailty in the ED may lead to rapid assessments and streaming of care for older patients which have shown to statistically significantly decrease ED LOS, which is why an early assessment by a physician potentially could decrease overall ED LOS. However, it is unknown how early assessed frailty could affect the ED visit itself.
In the beginning of 2025, the Emergency department of University hospital of Linköping launched a local guideline which recommended that patients aged 65 years or older visiting the ED should be assessed with CFS as early as possible, preferably in connection to triage. If the patients were assessed as living with frailty, the frailty score should be stated in the electronical overview of ED patients. The patient's needs of care should be induvidualized according to frailty level and the responsible clinical team should aim to decrease the ED length of stay for older patients living with frailty.
This study focuses on the outcomes of this newly implemented routine and aims to answer if recommended prioritization of older ED patients living with frailty leads to decreased ED LOS. Furthermore the study investigates if the clinical guidelines have an impact on time to the first assessment by a physician, admission rate, in-hospital length of stay, and mortality at 90 days
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Östergötland County
-
Linköping, Östergötland County, Sweden, 581 85
- Department of Emergency Medicine, University hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- 65 years of age or older
- Assessed by CFS with the score being documented in the electronic journal
Exclusion Criteria:
- Under the age of 65 years of age
- Not assessed by CFS
- Refusal of participation in the study
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Control group
Patients aged 65 years or older visisting the ED who have been assessed for frailty.
The control group were included before implementation of the local guidelines.
|
|
|
Intervention group
Patients aged 65 years or older visisting the ED who have been assessed for frailty.
The intervention group were included after the implementation of the local guidelines.
|
In the beginning of 2025, the Emergency department of University hospital of Linköping launched a clinical guideline which stated that patients aged 65 years or older should be assessed with CFS as early as possible, preferably in connection to triage.
If the patients were assessed as living with frailty, the frailty score should be stated in the electronical overview of ED patients.
The patient's needs of care should be met according to frailty level and the responsible clinical team should aim to decrease the ED length of stay for older patients living with frailty.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ED length of stay
Time Frame: From enrollment until end of inclusion, approximately 4-8 weeks for each group
|
Length of stay in the ED measured in hours and minutes (data will be collected from the electronic health record)
|
From enrollment until end of inclusion, approximately 4-8 weeks for each group
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to the first assessment by a physician
Time Frame: From enrollment until end of inclusion, approximately 4 weeks for each group
|
Time to the first assessment by a physician (measured in minutes)
|
From enrollment until end of inclusion, approximately 4 weeks for each group
|
|
Admission rate
Time Frame: From enrollment until end of inclusion, approximately 4-8 weeks for each group
|
Proportion of patients in each group that were admitted, measured in amount of patients and percentage.
|
From enrollment until end of inclusion, approximately 4-8 weeks for each group
|
|
In-hospital length of stay
Time Frame: From enrollment until end of inclusion, approximately 4-8 weeks for each group
|
Length of in-hospital stay, measured in days.
|
From enrollment until end of inclusion, approximately 4-8 weeks for each group
|
|
Mortality up to 90 days
Time Frame: From enrollment until end of inclusion, approximately 4-8 weeks for each group
|
Proportion of patients who deceased up to 90 days post ED-visit, including mortality at ED and in-hospital mortality.
Measured in amount of patients and percentage.
|
From enrollment until end of inclusion, approximately 4-8 weeks for each group
|
|
Difference in ED length of stay between patients in different triage categories
Time Frame: From enrollment until end of inclusion, approximately 4-8 weeks for each group
|
Difference in ED length of stay between patients in different triage categories, measured in hours and minutes.
The triage categories are: Red (priority 1), orange (priority 2), yellow (priority 3), green (priority 4), and blue (priority 5).
|
From enrollment until end of inclusion, approximately 4-8 weeks for each group
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Wretborn J, Munir-Ehrlington S, Horlin E, Wilhelms DB. Addition of the clinical frailty scale to triage tools and early warning scores improves mortality prognostication at 30 days: A prospective observational multicenter study. J Am Coll Emerg Physicians Open. 2024 Sep 9;5(5):e13244. doi: 10.1002/emp2.13244. eCollection 2024 Oct.
- Munir Ehrlington S, Horlin E, Toll John R, Wretborn J, Wilhelms D. Frailty is associated with 30-day mortality: a multicentre study of Swedish emergency departments. Emerg Med J. 2024 Aug 21;41(9):514-519. doi: 10.1136/emermed-2023-213444.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-05740-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Frailty
-
University of PennsylvaniaCompleted
-
McMaster UniversityRecruitingFrailty | Frailty Syndrome | Frail Older Adults | Frailty in AgingCanada
-
Universidad Francisco de VitoriaNot yet recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric Health
-
Universidad Francisco de VitoriaActive, not recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric HealthSpain
-
University of IcelandLandspitali University HospitalRecruitingFrailty Syndrome | Elective Surgery | Frailty in Adult SurgeryIceland
-
Ji Yan Biomedical Co., Ltd.YC Biotech Co., Ltd.Not yet recruiting
-
Universidad Francisco de VitoriaNot yet recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric Health
-
University of NottinghamRecruitingFrailty | Diet | Systemic Inflammatory Response | Dietary Fiber | Frailty at Older Adults | Pre-FrailtyUnited Kingdom
-
Maximilian KönigNot yet recruiting
-
Instituto Tecnologico y de Estudios Superiores...Not yet recruiting
Clinical Trials on Prioritized assessment for older patients living with frailty
-
International Geriatric Radiotherapy GroupBrigitta G. BaumertUnknownCOVID-19 Pneumonitis
-
The First Affiliated Hospital of Bengbu Medical...Enrolling by invitation
-
Vanderbilt-Ingram Cancer CenterEntrinsic Bioscience Inc.TerminatedNeuroendocrine Tumor | Carcinoid SyndromeUnited States
-
University Hospital, Basel, SwitzerlandRecruitingTriage Risk StratificationSwitzerland
-
University Hospital, Basel, SwitzerlandCompletedTriage Risk StratificationSwitzerland
-
Weill Medical College of Cornell UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedCardiovascular Diseases | Rheumatoid Arthritis | HyperlipidemiasUnited States
-
Norwegian Institute of Public HealthUniversity of Oslo; Oslo University Hospital; Oslo MunicipalityActive, not recruitingHip Fractures | Fall Injury
-
University Hospital, Clermont-FerrandRecruitingColon Neoplasm | Neuropathy;Peripheral | Cancer, LungFrance